These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 20399917
1. Timing of growth hormone treatment affects trabecular bone microarchitecture and mineralization in growth hormone deficient mice. Kristensen E, Hallgrímsson B, Morck DW, Boyd SK. Bone; 2010 Aug; 47(2):295-300. PubMed ID: 20399917 [Abstract] [Full Text] [Related]
2. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W, Briody J, Moore B, Lu PW, Cowell CT. Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578 [Abstract] [Full Text] [Related]
3. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD. Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U. Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865 [Abstract] [Full Text] [Related]
4. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults]. Wilhelm B, Kann PH. Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072 [Abstract] [Full Text] [Related]
10. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures]. Kuzma M, Payer J. Cas Lek Cesk; 2010 Oct 15; 149(5):211-6. PubMed ID: 20629339 [Abstract] [Full Text] [Related]
11. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects. Amato G, Izzo G, La Montagna G, Bellastella A. Clin Endocrinol (Oxf); 1996 Jul 15; 45(1):27-32. PubMed ID: 8796135 [Abstract] [Full Text] [Related]
15. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG. Growth Horm IGF Res; 2008 Aug 15; 18(4):318-24. PubMed ID: 18289903 [Abstract] [Full Text] [Related]
16. The importance of growth hormone replacement therapy for bone mass in young adults with growth hormone deficiency. Attie KM. J Pediatr Endocrinol Metab; 2000 Sep 15; 13 Suppl 2():1011-21. PubMed ID: 11086656 [Abstract] [Full Text] [Related]
18. [Dynamic effects of glucocorticoid on bone mineral density and microarchitecture: experiment with rats]. Liu SP, Chen J, Yang SM, Wu XP, Liao EY, Sheng ZF, Mo H, Ma YL, Zhang YH, Liu W, Jin Y, Dai RC. Zhonghua Yi Xue Za Zhi; 2008 Aug 19; 88(32):2281-4. PubMed ID: 19087680 [Abstract] [Full Text] [Related]
19. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. Pierroz DD, Bouxsein ML, Rizzoli R, Ferrari SL. Bone; 2006 Aug 19; 39(2):260-7. PubMed ID: 16531131 [Abstract] [Full Text] [Related]
20. Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by affecting intestinal calcium and phosphorus absorption. Masuyama R, Nakaya Y, Katsumata S, Kajita Y, Uehara M, Tanaka S, Sakai A, Kato S, Nakamura T, Suzuki K. J Bone Miner Res; 2003 Jul 19; 18(7):1217-26. PubMed ID: 12854831 [Abstract] [Full Text] [Related] Page: [Next] [New Search]